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ABSTRACT Fluorescence resonance energy transfer (FRET) was used to reveal aspects of the mechanism of signal
transduction by epidermal growth factor receptors (EGFR). The superpositions of epidermal growth factor (EGF), transforming
growth factor- (TGF) and an antibody fragment (29.1) to the carbohydrate extremity of the receptor’s ectodomain as
measured by FRET, show that 14% of EGFRs in A431 cells are oligomerized before growth factor binding. After binding
growth factor and signaling, these oligomers dissociate before releasing growth factor. Time courses of the FRET-derived
distances between constitutively oligomerized EGFRs during signal transduction show a transient structural change in the
extracellular domain, which occurs simultaneously with the production of intracellular Ca2 signals. The FRET measurements
also show a slow increase in oligomerization of EGFR monomers after growth factor binding. The structural change found in
the extracellular domain of oligomeric EGFRs is similar to that shown by others for EPO, Neu, Fas, and tumor necrosis factor
receptors, and may therefore be a common property of the transduction of the receptor-mediated signals.
INTRODUCTION
An epidermal growth factor receptor (EGFR) is a transmem-
brane receptor tyrosine kinase (RTK) that mediates the biolog-
ical signal of small polypeptide mitogens, including epidermal
growth factor (EGF) and transforming growth factor-
(TGF) (Carpenter and Cohen, 1979; Derynck et al., 1984).
This 170-kDa glycoprotein formed from a single polypeptide
chain of 1186 amino acids can be divided into a number of
functional domains (Carpenter, 1987). The heavily glycosy-
lated 622-amino acid residue amino-terminal extracellular do-
main contains the growth factor binding site. A single -helix
of 23 residues forms the transmembrane region. The 542-
residue cytoplasmic domain contains a 250-amino acid ty-
rosine kinase region and a 229-residue carboxy-terminal tail
with five tyrosine residues (Hartmann and Kohlbacher, 1998),
which when phosphorylated upon activation of the tyrosine
kinase act as docking sites for effector proteins containing Src
homology 2 (SH2) domains (reviewed by Pawson, 1995).
These include Grb2, GAP, Shc, phospholipase C (PLC),
and phosphatidylinositol 3-kinase (PI3K), which regulate Ras/
Rho-like GTPases, Ca2 second messenger production, and
the MAP/SAP kinase pathways, leading to cell proliferation,
changes in cell morphology, trafficking, and endocytosis (Car-
penter, 2000).
The mechanism by which the binding of growth factor to
the extracellular domain of EGFR activates the cytoplasmic
tyrosine kinase is not fully understood. It is, however,
known that EGFR dimerization is a requirement for activa-
tion. This is supported by data showing that EGFR cross-
linking and growth factor-induced receptor dimerization
lead to activation of EGFR’s kinase via inter-receptor in-
teractions (Bo¨ni-Schnetzler and Pilch, 1987; Yarden and
Schlessinger, 1987a, b; Cochet et al., 1988). In light of these
results, an allosteric oligomerization model for EGFR acti-
vation was developed to describe the events by which the
growth factor signals are transduced by EGFR across the
plasma membrane (Schlessinger, 1988). In this model inac-
tive EGFR monomers are in equilibrium with activated
EGFR oligomers, which were postulated to have higher
ligand-binding affinity. Consequently, the model implies
that EGF binding stabilizes the oligomeric state of EGFR in
which interactions between cytoplasmic domains result in
trans-autophosphorylation. It was proposed that this mech-
anism might be shared by other RTKs (Schlessinger, 1988).
The presence of allosteric oligomerization has been con-
firmed by x-ray crystallography for the fibroblast growth
factor (FGF) and the insulin receptors (Plotnikov et al.,
1999; Hubbard et al., 1994). Despite the absence of crys-
tallography data, some predictions of the allosteric oli-
gomerization model have also been verified for the EGFR
using molecular biology, biochemical, and biophysical
methods. High-affinity (KD  1 nM) and low-affinity (KD
 10 nM) EGF/EGFR interactions were found to be a
general occurrence in most cell lines, and these regulate
EGFR cytoplasmic interactions with endocytic proteins
(Boonstra et al., 1985; Ringerike et al., 1998). The high-
affinity binding state was also found to be the means by
which EGF stimulates cells both in vitro and in vivo
(Aboud-Pirak et al., 1988; Defize et al., 1989; Bellot et al.,
1990). Moreover, a link between high-affinity EGF binding
and EGFR dimerization has been demonstrated by the in-
creased affinity of cross-linked dimeric EGFRs (Sorokin et
al., 1994) and latterly by observing the formation of dimeric
high-affinity EGF/EGFR complexes using single-molecule
fluorescence microscopy (Sako et al., 2000).
There is, however, evidence that EGFR activation may
not just occur within an EGFR dimer, but also depend on
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interactions among EGFR dimers, secondary dimerization,
heterodimerization, modulation by multiple ligands, cross-
talk with other receptors, and ligand-independent lateral
propagation of activation (Defize et al., 1989; Gamett et al.,
1997; Verveer et al., 2000). In addition, it has also been
proposed that “inactive” high-affinity EGFR may be present
in significant numbers in cells without first binding EGF
(Gadella and Jovin, 1995). These fluorescence resonance
energy transfer (FRET) experiments in A431 cells showed
high-affinity EGF/EGFR complexes to be oligomerized af-
ter growth factor challenge at 4°C. Therefore, assuming that
EGF-induced dimerization, which is known to be tempera-
ture-dependent (Yarden and Schlessinger, 1987a), is totally
inhibited at this temperature, Gadella and Jovin (1995)
proposed that high-affinity EGFRs must have been consti-
tutively oligomerized before binding EGF. As high-affinity
receptors can be activated by EGF (Defize et al., 1989), the
proposed unliganded oligomers must therefore have been
prevented from phosphorylating their partner receptors’ in-
tracellular domains by the extracellular domains (Chantry,
1995). Consequently, some form of structural rearrangement in
the extracellular domain of EGFR presumably would have to
take place for signaling to occur after growth factor binding.
This, in essence, would combine the allosteric effect proposed
by Schlessinger (1988) with the concept of signal transduction
occurring through constitutive dimer receptors accompanied
by a ligand-induced conformational change in the EGFR’s
ectodomain. A mechanism such as this would be in line with
results found for the EPO, Neu, Fas, and tumor necrosis factor
receptors (reviewed by Jiang and Hunter, 1999).
To investigate these assertions we have measured the
efficiency of FRET between fluorescently labeled monoclo-
nal anti-EGFR Fab fragments, EGF, and TGF bound to
live A431 cells during the early stages of EGFR signal
transduction. FRET is the transfer of excited-state energy
from a donor fluorophore to an acceptor species with an
efficiency that depends on the sixth power of donor-accep-
tor distances (Stryer and Haugland, 1967), and can therefore
be used to quantify donor/acceptor distances in the range
between 2 and 10 nm. All ligands used, EGF, TGF, and
antibody fragments to EGFR’s ectodomain, bind with a 1:1
stoichiometry (Lemmon et al., 1997; Chu et al., 1997), and
the antibody fragments do not oligomerize or activate
EGFR (Schreiber et al., 1983). Therefore, the FRET-derived
distance between these ligands can be used to investigate
the state of receptor oligomerization before growth factor
binding, and also to follow any conformational changes that
may occur during the early events of signal transduction.
Quantification of intermolecular distances via FRET was
achieved by the measurement of fluorescence decay profiles
(Martin-Fernandez et al., 1996, 1998). This method has the
advantage of a simpler conversion of fluorescence lifetimes to
donor/acceptor distance. The equivalent steady-state measure-
ment of FRET is often ambiguous because of photobleaching
and trivial transfer (Hartmann et al., 1998). The data provide
evidence for the existence of constitutive high-affinity EGFR
oligomers in A431 cells, and suggest that signal transduction
involves a structural change in the extracellular domain of
EGFR.
MATERIALS AND METHODS
Cell culture
A431 cells purchased from the European Collection of Animal Cell Cul-
tures (ECACC) were grown in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 10% fetal calf serum (FCS) (v/v) and 4 mM
L-glutamine (Life Technologies, Paisley, UK) at 37°C in the presence of
5% CO2. Cells for fluorescence measurement were seeded on glass cov-
erslips at a density of 60,000 cell/cm2 and incubated for 24–36 h. At 12–24
h before use the cells were further incubated in DMEM containing 0.1%
FCS (v/v) at 37°C in the presence of 5% CO2. A431R cells were derived
from A431 cells as described by Nelson and Fry (1997).
Protein conjugation with fluorescent dyes
Fab fragments of the monoclonal antibody 29.1 (Sigma Aldrich, Gillingham,
UK) and the monoclonal antibody 255 (CalBiochem, Nottingham, UK) were
prepared using the ImmunoPure Fab preparation kit 44885 (Pierce and War-
rimer, Chester, UK), and characterized by molecular size exclusion chroma-
tography on a calibrated Superose 12 FPLC column (Pharmacia, Amersham,
UK). The fragments eluted as a single peak, corresponding to a molecular mass
of 49,300, showing complete digestion of the antibody and removal of the Fc
fragments. Fab 29.1, Fab 255, human recombinant EGF, and TGF (Pepro-
tech, London, UK) were dissolved in phosphate-buffered saline (PBS) to a
concentration of 1 mg/ml. The pH was raised to 8.3 by adding 10% (v/v) 1 M
sodium bicarbonate; 1:1 dye/protein conjugates of Alexa 488 sulfonated rho-
damine-derivative were prepared as described in the Alexa labeling kit
A-10235 (Molecular Probes, Leiden, The Netherlands). Erythrosin-isothiocya-
nate (Molecular Probes) was dissolved in DMSO to a concentration of 25
mg/ml and appropriate aliquots of dye were added to the protein for 1 h at
room temperature to obtain 1:1 dye/protein conjugates. Conjugates were
separated from free dye by gel filtration using a PD 10 column equilibrated
with PBS and were assayed in a spectrophotometer by using molar extinction
coefficients at 280 nm (protein), 488 nm (Alexa), and 529 (Erythrosin) (ex-
tinction coefficients of 71,000 and 90,000, respectively). Conjugates that
deviated by5% from a 1:1 dye/protein ratio were used. Aliquots were stored
at 85°C until required.
Cell-binding experiments
Coverslips with cells at 80–90% confluency were mounted in a tempera-
ture-controlled chamber (Intracel, Herts, UK), washed for 8–10 min in
Ca2 and Mg2-free Hanks’ balanced salt solution (Gibco, Paisley, UK),
then chilled to 4°C. Cells were then incubated for 1 h at 4°C with EGF or
TGF. Growth factor was applied to the cells in a 1:2 mixture of donor-
labeled growth factor to acceptor-labeled growth factor. This ensured that
80% of fluorescent receptor pairs (i.e., containing at least one donor-
ligand) had a FRET partner. This was calculated using the binomial
distribution. The probability of having a given number of acceptors (w) in
a receptor cluster containing n receptors is P(w)  [n!/(n  w)!w!] 
pwqnw. For a 1:2 donor/acceptor ratio and in the case of receptor dimers,
n  2, w  1, p(acceptor)  2/3, q donor)  1/3. Substituting in the
formula, P(1)  4/9 and P(0)  1/9. Therefore, P(1)/P(0)  P(1)  0.8.
A control experiment was run in which a 1:2 ratio of donor growth factor
to unlabeled growth factor was used. The total growth factor concentration
in each case was 150 nM, which saturates most receptor binding sites in
A431 cells (Rees et al., 1984; Chu et al., 1997). For Fab 29.1 fragment-
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binding experiments cells were incubated for 2 h at 4°C with a mixture of
fluorescent-labeled and -unlabeled Fab fragments at a total concentration
of 300 nM. A binding assay showed this concentration to saturate EGFR
binding sites in A431 and A431R cells. Nonspecific binding was deter-
mined for Fab 29.1, EGF, and TGF in the presence of 100 excess
unlabeled protein and found to be 20% in all cases. For simultaneous Fab
29.1 and growth factor binding, cells were incubated for 2 h at 4°C with a
300 nM solution of acceptor-labeled Fab, and then further incubated for 1 h
at 4°C with a 150 nM solution of donor-labeled growth factor. All solutions
were prepared in PBS containing 0.2% (w/v) bovine serum albumin (BSA).
Unbound EGF, TGF, or Fab fragments were removed by extensively
washing with ice-cold PBS. For high-affinity binding, cells were pre-
incubated for 4 h at 4°C with a 300 nM solution of the monoclonal
antibody 2E9 (TCS Biologicals, Northampton, UK) dissolved in PBS.
Intracellular calcium measurements
Cells bound to coverslips were incubated for 1 h with a 3 M solution of
internalizable Fluo-3 and 3 M Fura-Red dye (Molecular Probes) at 37°C.
Unincorporated dye was removed by washing with PBS. The cells were
then cooled to 4°C and incubated for 4 h with a 300 nM solution of
antibody 2E9, or for 1 h with a 300 nM solution of Fab 29.1, and then
exposed to 150 nM unlabeled EGF at 4°C. Similar experiments were run
with a pulse of EGF or TGF flowing over the cells at 37°C. [Ca2] time
courses were recorded on increasing the temperature to 37°C from the
fluorescence intensity ratio of Fluo-3 and Fura-Red dyes (Novak and
Rabinovitch, 1994). Both dyes were excited at 470 nm. A calibration was
obtained using ionophore A23187-permeabilized cells in the presence of
different concentrations of extracellular Ca2.
Fluorescence measurements
Fluorescence decays were recorded using time-resolved fluorescence micros-
copy (Martin-Fernandez et al., 1996). The field of view of the microscope was
selected to be completely filled with just-confluent cells, and contained a group
of 	50 cells. Samples were excited with pulsed synchrotron light at a repe-
tition rate of 3.125 MHz on station 13.1b of the SRS at CLRC Daresbury
Laboratory. Excitation of the samples was at 470 nm, and the emission was
recorded between 520 and 540 nm by means of an interference filter so that the
excitation light and acceptor fluorescence were eliminated. Confocal images
were collected with a CW argon ion laser. Anisotropy decays were collected
by measuring the components of the fluorescence decay parallel [Ipar(t)] and
perpendicular [Iper(t)] to the linearly polarized excitation light: r(t)  (Ipar 
Iper)/(Ipar  2Iper) with a polarizing microscope as described elsewhere (Mar-
tin-Fernandez et al., 1998).
Data analysis
Fluorescence decay parameters were calculated after subtraction of the fluo-
rescence background decay, which is composed of a 60:40 ratio of fluores-
cence background of the microscope and autofluorescence from cells. For the
same illumination we found fluorescence background variations of 10%
between cell preparations (as deduced from background values measured in 20
samples at 4°C). Time-courses of the fluorescence background were collected
from unlabeled samples and subtracted from each labeled sample data set
according to data frame collection time. This method resulted in the best
goodness of fit (2). After background subtraction, the decay data were
reconvoluted with the excitation profile using the program FLUOR (Gregory
et al., 1994). Fits were considered good for 2 between 0.8 and 1.2.
The FRET measured between different combinations of fluorescence donor
and acceptor probes bound to the ectodomain of EGFR was used both to
distinguish between the monomer and oligomeric states of the receptor and to
detect gross structural changes; 1:1 dye-protein conjugates displayed multiex-
ponential decay behavior in solution and were best fitted by the bi-exponential
law, with a short component (for Alexa 488,  1.12 ns) contributing 	25%
of the fluorescence decay together with a long component (  3.75 ns). In
cells, fluorescence decays were also best fitted by the bi-exponential decay law
after background subtraction. A single lifetime component of the analysis
could not be attributed to an individual population of receptors. Nevertheless,
the weighted mean fluorescence lifetime [
  (112  222)/(11  22)]
derived from the fluorescence decay represents the average time a fluorophore
exists in the excited state, being therefore sensitive to the donor/acceptor
distance and a suitable reporter for protein oligomerization (Lakowicz, 1983).
The use of the weighted mean lifetime was an operational choice to avoid
undue weighting of short lifetime components and light scattering. Although
the value of the first-order lifetime [(11  22)/(1  2)] is proportional
to fluorescence intensities and less biased to the contributions of long lifetime
components, we chose the weighted mean lifetime for FRET calculations
because it is a more stable quantity and therefore less prone to instrumental
biases. Our calculations showed that the FRET-derived distances using the
first- or second-order average lifetimes are in fact indistinguishable. This is
because the numerical difference cancels in the calculation.
The efficiency of FRET (E) was determined from the observed fluo-
rescence lifetimes of the donor in the presence 
da and absence 
d of
acceptor (Lakowicz, 1983) after being corrected using 0.8
dac   0.2
d 

da. This takes into account the 20% of donors without acceptor partner,
E  1  
dac /
d. Intermolecular distances were calculated by R 
R0[E1  11/6], where R0 is the Fo¨rster radius or the distance at which the
efficiency of energy transfer is 0.5, which equated to 5.7 nm. R0 was
calculated for the donor/acceptor pair from the spectral overlap integral
J()  Fd()a()4d, where Fd() is the normalized emission from the
donor and a() is the normalized excitation from the acceptor multiplied
by the extinction coefficient, using R0  [8.8  1023 	2n4QYdJ()]1/6 Å;
QYd is the fluorescence quantum yield of the donor in the presence of the
acceptor, n is the refractive index of the medium, and 	2 is the dipole
orientation factor. We have estimated the rotational mobility of the Alexa
fluorophore to be very large and have assumed a value of 2⁄3 for the
orientation factor 	2 in our distance calculations.
Anisotropy decays were best fitted with the bi-exponential anisotropy
decay law plus a static term (Lakowicz, 1983) by r(t)  
1 exp(t/2) 

2 exp(t/2)  r, where 
i and r are the relative components of each
decay and the static component, respectively. The sum of these compo-
nents is equal to the anisotropy at time 0 and is related to the angles
between the emission and absorption dipoles; i are the rotational corre-
lation times, which are a function of the rotational rates that reflect the
segmental, wobbling, and global motions of the fluorescent label, ligand,
and bound receptor.
RESULTS
The primary objective of this work was to use FRET to
detect changes in oligomerization and structure of EGFRs
during cell signaling after activation by EGF and TGF.
The duty cycle of signaling occurs over several hours, and
therefore low illumination levels were necessary to avoid
cell damage. Synchronization of the receptors from 50 or so
cells within the field of view of the microfluorimeter was
achieved by performing the growth factor challenge at 4°C.
At this temperature high- and low-affinity EGF binding
occurs, but endocytosis is inhibited (Gadella and Jovin,
1995; Brown and Goldstein, 1979). This method enabled us
to investigate the EGF-induced oligomerization of EGFRs
in the cold and provided a method of initiating synchronized
cell signaling on raising the temperature to 37°C. Alterna-
tively, synchronization was achieved by exposing cells to a
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fast pulse of growth factor at 37°C through a flow system
attached to the microscope’s stage. To isolate the fluores-
cence of the high-affinity EGFRs responsible for cell sig-
naling (Aboud-Pirak et al., 1988; Defize et al., 1989; Bellot
et al., 1990), fluorescence from low-affinity EGFRs was
eliminated by blocking their binding to the fluorescent
growth factor (Gadella and Jovin, 1995). To further opti-
mize the fluorescence lifetime measurements the cells were
pretreated with Ca2-free buffer, which maximizes the
numbers of cell surface high-affinity EGFRs (Holley et al.,
1977).
The following section of the Results deals with the val-
idation of all the above conditions using A431 cells, which
overexpress EGFRs to a level of 1–2 million per cell (Fab-
ricant et al., 1977), and A431R cells that are depleted of
their high-affinity receptors (Nelson and Fry, 1997). In the
remaining sections, time-resolved fluorescence data are pre-
sented that are used to compare the mechanism of signal
transduction in EGFR with that of RTKs and other classes
of receptors.
High- and low-affinity receptor populations in
A431 cells
High- and low-affinity binding were distinguished by pre-
treating cells with the monoclonal anti-EGFR antibody 2E9,
which specifically blocks EGF binding to low-affinity
EGFRs (Defize et al., 1989). This antibody binds to the
protein core of EGFR with a 1:1 stoichiometry without
affecting the state of oligomerization of the receptor. The
percentage of high-affinity receptors on the surface of con-
fluent A431 cells was determined by comparing the residual
fluorescence intensity of untreated cells and cells pretreated
with mAb 2E9, after incubating cells with EGF labeled with
Alexa 488 (Al-EGF) and washing at 4°C to remove un-
bound dye-growth factor conjugate. The relative affinities
of Al-labeled and unlabeled growth factor were compared
by titration against each other while bound to cells (Fig. 1
A). This showed that the fluorescent label had not changed
the growth factor’s affinity for its receptor.
Pretreatment of cells with mAb 2E9 reduced the fluores-
cence intensity from bound Al-EGF by 93% over that from
untreated cells after correction for instrumental background
and cell autofluorescence (see Methods), indicating that 7%
of cell surface EGFRs were high-affinity (bars 1–3 in Fig. 1
B). This is in agreement with previous studies, which have
shown that between 1 and 12% of EGFRs exhibit high-
affinity EGF binding (Rees et al., 1984; Defize et al., 1989;
Gadella and Jovin, 1995). The same fluorescence readings
were obtained for Al-TGF binding before and after pre-
treatment with mAb 2E9.
Previous work has shown that the number of cell surface
high-affinity EGFRs is decreased at high cell density (Licht-
ner and Schirrmacher, 1990). Holley et al. (1977) showed
that EGFRs were removed from the surface by sequestration
as cells approached confluence, rendering them unable to
bind growth factor. This was proposed as the mechanism for
cell density-induced down-regulation of growth factor ac-
tion, sequestered receptors being termed “cryptic.” How-
ever, incubation of high-density A431 cultures in Ca2-free
buffer for as little as 10 min at 37°C both increases the
number of surface receptors able to bind growth factor and
restores mitotic activity to high-density cultures (Holley et
al., 1977; Suarez-Quian and Byers, 1993). Our work shows
that Ca2-free buffer treatment of high-density A431 cul-
tures resulted in an increase in high-affinity EGF and TGF
binding from 7% to 14% (bar 7 in Fig. 1 B), the latter value
approximating to the 12% previously observed in low-
density cultures (Rees et al., 1984). It would appear that this
treatment returns cryptic EGFRs to the cell surface. Ca2-
free buffer treatment was therefore used in this work before
fluorescence lifetime measurements to maximize signals
from high-affinity EGFRs (Fig. 1 B).
The modified cell line A431R is derived from A431 cells
by the specific suppression of EGFR tyrosine kinase activity
(Nelson and Fry, 1997). The absence of fluorescence above
background from confluent A431R cells exposed to Al-EGF
after blocking low-affinity EGFRs with mAb 2E9 (bar 5 in
Fig. 1 B) is consistent with the absence of high-affinity EGF
binding in these cells (Nelson and Fry, 1997). Fig. 1, C and
D are typical views of A431 and A431R cells, respectively,
exhibiting their characteristic morphologies, the latter ap-
pearing flattened. The treatment of confluent A431R cells
with Ca2-free buffer results in the restoration of cryptic
high-affinity EGFRs to a level approaching 5% of the total
growth factor binding capacity (Fig. 1 B). These data pro-
vide additional confirmation that the inhibited growth of
A431R cells due to cell-cell contact results from the down-
regulation of high-affinity receptors.
The absence of high-affinity EGFRs in confluent A431R
cultures should have provided a good experimental control
for high-affinity EGFR activity, but the fluorescence dis-
played by Al-EGF/TGF after treatment with Ca2-free
buffer and the low-affinity EGFR blocker mAb did not
provide enough signal above background for meaningful
lifetime analysis. However, besides the morphological dif-
ferences between A431 and A431R cells observed in Fig. 1,
C and D attributable to differences in actin organization, the
two cell types have similarly large numbers of EGFRs,
indistinguishable cell cycle characteristics, and respond
identically to growth factor (Nelson and Fry, 1997). There-
fore, we have used Ca2-untreated A431R cells as control
samples.
High-affinity EGFRs are oligomeric after binding
growth factor at 4oC
The state of oligomerization of high-affinity EGFRs on
A431 cells maintained at 4°C after growth factor binding
was determined by comparison of the fluorescence lifetimes
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of FRET donor Al-EGF or Al-TGF, with their unlabeled
and energy transfer acceptor erythrosin isothiocyanate (Er)-
labeled counterpart (Fig. 2) in a 1:2 donor/acceptor ratio.
Fig. 3 A shows the observed weighted mean fluorescence
lifetimes of donor-labeled growth factors bound to A431
and A431R cells. The fluorescence lifetime of Al-EGF
bound to A431 cells in a 1:2 ratio with unlabeled EGF, and
therefore in the absence of FRET, was 3.51 ns. After block-
ing low-affinity EGFR sites with the mAb 2E9, whose
binding did not affect the fluorescence lifetime of Al-EGF,
the fluorescence lifetime of donor Al-EGF bound to high-
affinity EGFR with acceptor Er-EGF had decreased to 3.25
ns (bars 1 and 2 in Fig. 3 A). This level of quenching is
small but clearly detectable above experimental noise, and
therefore confirms that the high-affinity EGFR population
contains a substantial proportion of oligomeric receptors
after binding EGF at 4°C, as previously reported (Gadella
and Jovin, 1995). The recent work of Sako et al. (2000)
would suggest that the oligomeric state of the high-affinity
EGFRs is in fact dimeric, although our experiment cannot
distinguish between dimers and higher oligomers. A con-
siderably smaller degree of fluorescence lifetime quenching
was observed when low-affinity EGFRs were left un-
blocked, suggesting that there was no large shift in the
population from monomers to oligomers after EGF binding
FIGURE 2 Selected donor fluorescence decays (raw data). (a) Fluores-
cence decay profile of Al-TGF bound to A431 cells in a 1:2 ratio with
unlabeled TGF (absence of FRET); (b) fluorescence decay profile of
donor Al-TGF bound to A431 cells in a 1:2 ratio with acceptor Er-TGF
after pretreatment with mAb 2E9 (showing FRET); (c) the pulsed instru-
mental response function. The time calibration is 0.046 ns/channel.
mAb 2E9 (2E9 in bar labels). Results are the mean of at least three
independent experiments. (C) Fluorescence confocal image of surface-
bound Al-EGF to A431 cells. The thickness of the sections is 0.7 m. (D)
Fluorescence confocal image of surface-bound Al-EGF to A431R cells.
Bar  20 m.
FIGURE 1 (A) Competitive binding of Al-EGF/unlabeled EGF (filled
circles), Al-TGF/unlabeled TGF (squares), and Al-Fab 29.1/unlabeled
Fab29.1 (open circles). A431 cells were incubated with 150 nM EGF or
300 nM Fab 29.1 (total concentration) at various ratios of unlabeled-ligand/
Al-ligand while being maintained at 4°C to inhibit endocytosis, as de-
scribed in Materials and Methods. (B) Histogram of the relative fluores-
cence intensity from A431 and A431R cells labeled with Al-EGF at 4°C.
Results from cells treated with Ca2-free buffer before EGF challenge are
indicated as Ca2 in bar labels. For high-affinity binding, cells were
pre-incubated for 4 h at 4°C with a saturating concentration (300 nM) of
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at 4°C (bar 3 in Fig. 3 A), in agreement with previous
observations (Gadella and Jovin, 1995).
The data in Fig. 3 A were used, after correction to take
into account the 20% donor/donor emission (see Materials
and Methods), to determine the efficiency of FRET and
hence the apparent FRET distances between donor and
acceptor species. An average distance between EGF mole-
cules bound to high-affinity receptors of 8.3 nm was deter-
mined from the efficiency of energy transfer, using the
Fo¨rster distance (R0) for this donor/acceptor pair of 5.7 nm.
This EGF-EGF distance is in agreement with that predicted
by Sako et al. (2000), but longer than that estimated by
Gadella and Jovin (1995) using the less accurate photo-
bleaching FRET technique (Hartmann et al., 1998). The
fluorescence anisotropies of bound donor EGF were low,
most likely signifying relatively free dye rotations (Table 1)
because rapid depolarization by homo-FRET (R0	 4.6 nm)
should be very small at the FRET efficiencies measured.
The anisotropy of Al-EGF bound to nontransferring low-
affinity EGFRs (Table 1) gave similar values, suggesting
that we can indeed discount unfavorable molecular orienta-
tions of the donor with respect to the acceptor that might
degrade the accuracy of the measurement (Haas et al., 1978).
On binding the TGF energy transfer pair to high-affinity
EGFRs at 4°C, the fluorescence lifetime of donor Al-TGF
was quenched from 3.66 ns to 2.18 ns (bars 4 and 6 in Fig.
3 A), corresponding to a TGFTGF distance of 5.7 nm.
The fluorescence anisotropy for Al-TGF was lower than
for Al-EGF (Table 1), and this might be due to the presence
of some homo-FRET, consistent with a TGFTGF dis-
tance 2.6 nm shorter than that found for EGF. This gives a
half-distance difference of 1.3 nm, which is well within the
growth factors’ largest molecular dimension of 	3.5 nm
(Harvey et al., 1991; Kohda and Inagaki, 1992).
There are three possible explanations for the apparent
intergrowth factor distance difference between EGF and
TGF. First, the locations of the dye conjugation sites on
three independent experiments. Error bars represent standard deviations.
(B) Relative positions between the fluorophores conjugated to EGF (open
circles), TGF (filled circles), and Fab 29.1 (squares) determined from the
fluorescence lifetime data in (A) after correction to take into account the
20% donor-donor labeled receptors (see Materials and Methods).
FIGURE 3 (A) Histogram showing the weighted mean donor lifetimes of
EGF, TGF, and Fab 29.1 fragments bound to EGFRs showing different
degrees of quenching due to FRET. The open bars show results from A431
cells treated with Ca2 buffer and incubated with a 1:2 mixture of donor
labeled growth factor and unlabeled growth factor (Al-growth factor/u-
growth factor); donor-labeled growth factor and acceptor-labeled growth
factor (Al-growth factor/Er-growth factor); donor-labeled growth factor
and unlabeled Fab 29.1 fragment (Al-growth factor/u-Fab); or donor-
labeled growth factor and acceptor-labeled Fab 29.1 fragment (Al-growth
factor/Er-Fab). Gray bars are results from A431 cells after incubation with
2E9. Black bars are results from A431R cells, which were not pre-
incubated with Ca2-free buffer, as this would have resulted in returning
high-affinity EGFRs to the cell surface. Binding incubations and decay
measurements were performed at 4°C and results are the mean of at least
TABLE 1 Anisotropy decay parameters for the fluorescent
ligands bound to EGFRs

1 1 
2 2 r
Al-EGF* 0.09 0.12 0.06 4.80 0.05
Al-EGF† 0.10 0.11 0.05 4.58 0.06
Al-TGF 0.05 0.17 0.02 5.02 0.04
Al-Fab 0.13 0.49 0.04 7.02 0.02
*Bound to high-affinity EGFR.
†Bound to high- and low-affinity EGFR. Results are the mean of three
independent experiments.
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EGF and TGF could be different. Second, the binding
orientation of EGF and TGF on EGFRs could also be
different. Third, binding sites for EGF and TGF could be
at different locations on the EGFR, as previously proposed
by Winkler et al. (1989) from antibody blocking experi-
ments. Further information on the location of growth factor
binding sites was obtained by determining the distances
between donor Al-EGF or Al-TGF and acceptor (Er)-
labeled Fab fragments of a monoclonal antibody (Fab 29.1)
simultaneously bound to EGFR. The Fab 29.1 antibody is
known to bind the carbohydrate moiety situated at the
extremity of the extracellular domain at some distance from
the growth factor binding site (Yarden et al., 1985). The
fluorescence intensities of Al-EGF and Al-TGF bound to
untreated cells and cells saturated with unlabeled Fab 29.1
were identical, confirming that growth factor binding was
not impeded by the Fab fragment. Fluorescence decay pro-
files of Al-EGF and Al-TGF bound to EGFR in cells
preincubated either with unlabeled Fab 29.1 or acceptor
Er-Fab 29.1 showed FRET-induced donor lifetime quench-
ing in the presence of acceptor (bars 8–11 in Fig. 3 A). The
fluorescence lifetime of Al-EGF was quenched from 3.50 ns
to 3.17 ns, corresponding to a distance of 7.9 nm, and the
lifetime of Al-TGF was quenched from 3.69 to 3.26 ns,
corresponding to 7.7 nm. These results agreed to within 0.2
nm when the donor and acceptor labels on growth factor and
Fab fragments were exchanged. This therefore points to the
close proximity of the EGF and TGF binding sites on the
EGFR as measured from the extremity of the external
domain. Whatever the origin of the apparent intergrowth
factor distance difference for EGF and TGF binding, how-
ever, the main conclusions of this work are unaffected.
In cells not pretreated with mAb 2E9, when a mixture of
donor Al-TGF and acceptor Er-TGF was bound to
EGFRs the donor lifetime was quenched to only 3.3 ns (bar
5), indicating the nonparticipation of low-affinity receptors
in lifetime quenching and monomer-monomer separations
in excess of that required for FRET. This was confirmed by
the total absence of FRET observed when a 1:2 ratio of
donor/acceptor TGF was bound to A431R cells that have
only low-affinity monomer EGFRs (bar 7 in Fig. 3 A).
High-affinity EGFRs are constitutive oligomers in
A431 cells
To investigate the state of aggregation of high-affinity EGFRs
before growth factor binding, A431 and A431R cells were
reacted with a mixture of donor- and acceptor-conjugated Fab
29.1 fragments. EGFR oligomerization is distinguished by the
quenching of the fluorescence lifetime of the donor antibody
fragment conjugate. This antibody fragment, although not
completely specific, as it is known to bind blood group-A
carbohydrate antigens (Gooi et al., 1983), did not impede
growth factor binding and therefore later enabled us to follow
oligomerization after binding. The initial oligomeric state was
also investigated using FRET measurements on donor- and
acceptor-conjugated Fab fragments of the monoclonal anti-
EGFR antibody 225, which exclusively binds to the EGF
binding site and therefore prevents EGR binding (Gill et al.,
1984). The donor fluorescence lifetimes of a 1:2 mixture of
donor Al-Fab 29.1 and acceptor Er-Fab 29.1-bound A431 cells
when compared with those from cells bound with a 1:2 mixture
of Al-Fab 29.1 and unlabeled Fab 29.1, showed a decrease of
0.21 ns (bars 12 and 13 in Fig. 3 A). The quenching of the
donor fluorescence lifetime with donor- and acceptor-conju-
gated Fab 225 bound to EGFRs in A431 cells by 0.19 ns
confirmed that the Fab 29.1 fragment was indeed reporting the
presence of oligomer EGFRs. No decrease in donor lifetime
was detected in confluent A431R cells (bar 14 in Fig. 3 A),
consistent with these cells being devoid of oligomers. These
data provide evidence for a measurable population of high-
affinity EGFR oligomers in A431 cells before growth factor
binding, confirming recent results obtained in NIH3T3 cells
(Moriki et al., 2001).
It could be argued that A431 cells, being a transformed
cell line, could secrete sufficient TGF (Derynck et al.,
1987) to give a significant population of “apparent” consti-
tutive oligomer receptors by growth factor-induced oli-
gomerization. This oligomeric state could not then be
termed constitutive. However, the FRET from donor- and
acceptor-conjugated Fab 225 bound to A431 cells remained
constant throughout a 5-min mild acid/salt extraction at 0°C
(pH 4.5), a procedure known to dissociate the TGF/EGFR
complex (Ebner and Derynck, 1991). This leads us to the
conclusion that autocrine binding of TGF plays no signif-
icant part in forming the observed population of oligomers,
which are therefore correctly termed constitutive because
they are formed before growth factor binding.
Deriving distances from the fluorescence lifetime
quenching of donor-conjugated Fabs in A431 cells proved
more complex than for dye-conjugated growth factors
bound to oligomeric EGFRs. In the latter case, blocking the
binding of dye-conjugated growth factors to monomers
rendered the lifetime analysis from oligomers trivial. This
was not possible for dye-conjugated Fabs, whose fluores-
cence therefore contained two components from high-affin-
ity EGFR oligomers and two components from non-energy-
transferring monomers. The distance between Fab 29.1
molecules bound to oligomeric EGFRs was therefore com-
puted using a multicomponent analysis of the fluorescence
decay data. Although the two additional exponential values
were determined from A431R cells and could therefore be
entered as constant lifetimes in the analysis, the additional
parameters to account for the pre-exponential components of
the unquenched lifetimes resulted in a loss in precision. The
analysis, however, returned a distance between Fab 29.1 frag-
ments bound to high-affinity receptors in the range from 6 to 7
nm (Fig. 3 B). Fluorescence anisotropy values (Table 1) again
showed a considerable freedom of rotation for the dye attached
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to the Fab/EGFR complex discounting adverse orientation
factors as a source of error in this calculation.
Using the fluorescence lifetime data given in Fig. 3 A, a
projection scaffold model is shown in Fig. 3 B to summarize
the FRET-derived average distances between ligands con-
jugated to high-affinity EGFR at 4°C. In this model we have
made two assumptions: first, that all oligomeric EGFR are
dimers; second, that these dimers have a twofold symmetry.
The distances represent average distances between donor
and acceptor fluorophores even though conjugates are la-
beled 1:1. We cannot claim that every fluorophore is co-
valently bound to unique sites.
A temperature-responsive structural change in
EGFR’s extracellular domain
FRET measurements were also used to investigate the
changes in receptor oligomerization on binding unlabeled
growth factor at 4°C and during the subsequent temperature
jump to 37°C. The calculation of the time course for FRET
efficiencies required two data sets from samples of cells
grown under identical conditions. The first data set was
recorded by collecting donor fluorescence decay profiles for
a 1:2 ratio donor/acceptor bound species, an example of
which is shown in Fig. 4 A. The second was from a similar
procedure but with the acceptor-conjugated species replaced
by unlabeled ligand (Fig. 4 B). In this way, the effect of
changing the temperature on the fluorescence lifetime was
removed from the calculation of FRET efficiencies.
The above method was used to monitor changes in the
distance between EGFRs on addition of EGF. The time
course for the efficiency of FRET for donor/acceptor-la-
beled Fab 29.1 bound to EGFRs on A431 cells is plotted in
Fig. 5 A. The initial level of FRET arises from constitutive
EGFR oligomers, albeit contaminated with a large fluores-
cence contribution from nontransferring donor EGFR
monomers. When unlabeled EGF was added at 4°C there
was no change in the FRET efficiency, and therefore major
changes in distance between EGFR ectodomains did not
occur at this temperature. A small, transient decrease in the
efficiency of FRET between EGFR-bound Fab fragments
was recorded for A431 cells on increasing the temperature
from 4°C to 37°C (Fig. 5 A), but was not observed in
A431R. This transient was not simply the response of the
receptor’s structure or the fluorophore emission to the tem-
perature change because a similar transient was observed in
donor/acceptor Fab-labeled A431 cells during exposure to a
pulse of EGF at a constant 37°C (Fig. 5 B). The slower
response to EGF at 4°C is presumably a result of stresses on
the cells caused by refrigeration. As cells decorated with
Fab 29.1 fragments underwent normal EGF-induced intra-
cellular Ca2 transients (Fig. 5 C) (Defize et al., 1989;
Tinhofer et al., 1996; Peppelenbosch et al., 1996), we con-
clude that a transient distance increase between the extrem-
ities of the extracellular domains of high-affinity EGFR
occurs during EGFR signaling. This transient could be the
result of a structural rearrangement within the external
domains of oligomeric EGFR or the transitory dissociation
and re-association of a proportion of oligomers.
The time course of the efficiency of FRET between donor/
acceptor-labeled EGF molecules also showed a transient
change on increasing the temperature from 4°C to 37°C (Fig.
6 A, triangles). This transient corresponds to a change in the
distance between the fluorescent moieties of EGF molecules
bound to high-affinity EGFR from 8.3 to 8.7 nm (Fig. 6 B,
triangles). Cells exposed to antibody mAb 2E9 were also
found to retain their signaling competence by a growth factor-
induced transient increase in intracellular Ca2 (Fig. 6 B,
continuous line). A short time after the transient, the distance
between EGF molecules began to increase progressively (Fig.
FIGURE 4 (A) Time course of the temperature change in cells (contin-
uous line). Example of time course of the fluorescence lifetime of Al-
TGF bound to A431 cells at 4°C in a 1:2 ratio with acceptor Er-TGF
(uncorrected) after pretreatment with mAb 2E9 (circles). (B) Example of
time course of the fluorescence lifetime of Al-TGF in a 1:2 ratio with
unlabeled TGF. The fast initial decrease in (A) and (B) is a temperature-
induced effect in the fluorescence lifetime.
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6 B, triangles), indicating either oligomer dissociation or the
dissociation of EGF from oligomeric EGFRs. Fig. 6, A and B
(filled circles), which report mostly on the majority monomer
EGFR population, show a gradual increase in FRET over a
period of 20 min after the temperature jump. This is indicative
of a slow monomer secondary oligomerization phase, as pre-
viously shown (Gadella and Jovin, 1995; Blakely et al., 2000).
However, the data in Fig. 6 B can only be interpreted qualita-
tively because of the large error introduced by the majority
component of the fluorescence arising from nontransferring
monomer EGFRs.
Changes in the efficiency of FRET between donor Al-EGF
and acceptor Er-Fab 29.1 bound to dimer EGFRs in A431 cells
were recorded and the corresponding distances calculated (Fig.
6, A and B, open circles). The distance between the fluoro-
phores of Al-EGF and Er-Fab again shows a fast transient
increase from 7.9 to 8.2 nm on raising the temperature from
4°C to 37°C. Unlike the time course of donor/acceptor-labeled
EGF, the transient is not followed by the slow increase in
inter-receptor distance. Therefore, this FRET occurs between
dye-growth factor and dye-Fab 29.1 conjugates bound to the
same EGFR ectodomain, and must reflect a structural change
in the extracellular domain of EGFR. Moreover, this indicates
that the slow increase in EGF-EGF separation after the FRET
transient (Fig. 6, A and B, open circles) is due to EGFR
oligomer dissociation rather than oligomer–growth factor
dissociation.
The time course of FRET between donor Al-TGF and
acceptor Er-TGF bound to high-affinity EGFRs after block-
ing low-affinity EGFRs with mAb 2E9 also showed a transient
increase in the TGFTGF distance from 5.7 to 5.9 nm in
response to the temperature jump (Fig. 7, A and B, triangles).
This transient was again followed by a slow progressive in-
crease in distance as EGFR oligomers dissociate. The transient
was much less pronounced when both high- and low-affinity
EGFR were labeled, as for EGF, because of the high back-
ground from low-affinity monomer EGFRs (Fig. 7, A and B,
filled circles). The distance between donor Al-TGF and ac-
ceptor Er-Fab simultaneously bound to dimer EGFRs shows a
similar transient increase to that for EGF signaling, from 7.7 to
7.9 nm (Fig. 7, A and C, open circles). No increase in the
distance between TGF and Fab 29.1 was observed after the
transient, confirming that these distances report on the
separation between a TGF molecule and a Fab fragment
bound to the same molecular component of the EGFR
oligomer. These results confirm our previous conclusions
from the EGF experiments.
DISCUSSION
The FRET data presented suggest that in A431 cells the
binding of EGF or TGF to high-affinity constitutive EGFR
oligomers, i.e., the functional receptor moiety, leads to
signal transduction and to a structural change in the recep-
tor’s extracellular domain. These results therefore indicate
FIGURE 5 (A) Time course for the efficiency of FRET of Al-Fab 29.1
bound to A431 cells pretreated with Ca2-free buffer at 30 s per datum. An
ice-cold solution of EGF (150 nM) was added at the time indicated by the
arrow and rinsed with PBS before the temperature was increased to 37°C
(continuous line). Results are the mean of at least three independent experi-
ments with a variance of10%. (B) As in (A), but at 11 s per datum. A 37°C
solution of EGF (150 nM) in PBS was added to the cells and rinsed with PBS,
as indicated by the figure (dashed line). (C) Time course of Ca2mobilization
in A431 cells pre-equilibrated at 4°C with 300 nM unlabeled Fab 29.1,
measured by monitoring Fluo-3 and Fura-Red fluorescence induced by the
addition of a 150 nM solution of EGF (black line) or TGF (gray line) in PBS,
as shown in (B).
Preformed Oligomer-EGFR Structure Change 2423
Biophysical Journal 82(5) 2415–2427
that ligand-induced oligomerization cannot be an absolute
requirement for the onset of RTK signal transduction, as
suggested by the allosteric signaling mechanism of RTK
activation (Schlessinger, 1988).
The existence of constitutive oligomer EGFRs (probably
dimers) (Sako et al., 2000), has previously been reported. A
FIGURE 6 (A) Time course for the efficiency of FRET between donor/
acceptor-labeled EGF bound to EGFRs during signaling as derived from
fluorescence lifetime data following a temperature jump from 4°C to 37°C
(continuous line). Efficiency of transfer between Al-EGF and Er-EGF bound
to surface EGFRs in A431 cells pretreated with Ca2-free buffer (filled
circles); Al-EGF and Er-Fab (open circles); and high-affinity Al-EGF and
Er-EGF in cells pretreated with mAb 2E9 (triangles). (B) Time course for the
distance between Al-EGF and Er-EGF bound to both high- and low-affinity
EGFRs (filled circles); Al-EGF and Er-EGF bound to high-affinity EGFRs
(triangles); and Al-EGF and Er-Fab (open circles) calculated from the FRET
efficiency data. Results are the mean of at least three independent experiments
with a variance of 5%. EGF-induced Ca2 mobilization originated by
high-affinity EGFR binding followed by monitoring Fluo-3 and Fura-Red
fluorescence (continuous line).
FIGURE 7 (A) Time course for the efficiency of FRET between donor/
acceptor-labeled TGF bound to EGFRs during signaling as derived from
fluorescence lifetime data following a temperature jump from 4°C to 37°C
(continuous line). Efficiency of transfer between Al-TGF and Er-TGF
bound to surface EGFRs in A431 cells pretreated with Ca2-free buffer
(filled circles); Al-TGF and Er-Fab (open circles); and high-affinity
Al-TGF and Er-TGF in cells that had been pretreated with mAb 2E9
(triangles). (B) Time course of the distance between Al-TGF and Er-
TGF bound to both high- and low-affinity surface EGFRs (filled circles),
and high-affinity EGFRs (triangles), calculated from the FRET efficiency
data. (C) Distance between Al-TGF and Er-Fab (open circles). Results
are the mean of at least three independent experiments with a variance of
5%.
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small level of pre-dimerization has been found in live A431
cells by cross-linking and 
-galactosidase complementation
studies (Bo¨ni-Schnetzler and Pilch, 1987; Cochet et al.,
1988; Sorokin et al., 1994; Chu et al., 1997; Blakely et al.,
2000). Preformed EGF receptor dimers have also been
found in NIH3T3 cells using chemical cross-linking and
sucrose density-gradient centrifugation (Moriki et al.,
2001). For other receptors, x-ray crystallography, spectro-
scopic, and biochemical methods have also demonstrated
the existence of inactive pre-dimerized erythropoietin re-
ceptors (EPOR), tumor necrosis factor, and Neu receptors
(review by Jiang and Hunter, 1999). However, in the case of
A431 cells it could be argued that the presence of constitu-
tive oligomeric EGFRs might merely be a product of EGFR
overexpression. We do not think this can be the case for two
reasons: first, because A431R cells, which overexpress
EGFR to identical levels (Nelson and Fry, 1997), have far
less constitutive oligomers (Fig. 3); second, because chem-
ical cross-linking and sucrose density-gradient centrifuga-
tion data have shown that in NIH3T3 cells, which express
EGFR at physiological levels, EGFR forms constitutive
dimers at the cell surface (Moriki et al., 2001). There is
sufficient evidence for the presence of constitutive oli-
gomers for their role in signal transduction to have some
significance.
The binding of EGF to EGFRs is known to promote RTK
activation even at 4°C (McCune and Earp, 1989; Sorokin et
al., 1994; Ringerike et al., 1998). At 4°C, however, our
FRET results (Fig. 5 A) suggest that EGF binding does not
cause structural changes that result in a significant increase
in distance between EGFR ectodomains, which would be
measurable by FRET. The absence of FRET changes there-
fore suggests that tyrosine kinase activity in EGFR is not
associated with the “rocking motion”-like structural
changes observed in EPOR, which have been shown to lead
to receptor activation (Remy et al., 1999). Our data are,
however, consistent with the “flexible rotation” model for
EGFR activation proposed by Moriki et al. (2001), as the
reported EGF-induced rotation of the transmembrane do-
main would not result in significant distance changes be-
tween EGFR ectodomains. In contrast with our FRET re-
sults at 4°C, the growth factor-induced structural change
observed on raising the temperature to 37°C (Figs. 4, 6, and
7), which must therefore occur after EGFR tyrosine kinase
activation, is consistent with a rocking motion similar to that
described for EPOR (Remy et al., 1999). If this structural
change has any physiological relevance, it might be related
to one or several of the temperature-responsive processes
occurring in EGFR signaling. Examples of these processes
are EGFR’s phosphorylation of substrates (McCune and
Earp, 1989); formation of ruffles (Rijken et al., 1991);
high-affinity EGFR binding to actin microfilaments
(Zidovetzki et al., 1991); desensitization of EGFR, by
which EGFR loses the ability to dimerize in response to a
second EGF challenge (Kuppuswamy and Pike, 1989); and
the production of Ca2 second messenger (Fig. 6 B). Ca2
transients have been shown to be mediated by EGFR’s
phosphorylation of the oncogenic GTP-binding proteins Ras
and Rac (Tinhofer et al., 1996; Peppelenbosch et al., 1996),
the latter directly mediating the formation of ruffles (Ridley
et al., 1992). The excellent time correlation between the
structural change in EGFR and the measured Ca2 tran-
sients (Figs. 5 and 6) suggests that these two events might
be related. It is therefore possible that the transient structural
change in the extracellular domain of EGFRs can be one of
the events facilitating the binding of EGFR cytoplasm do-
main to those substrates generating growth factor-induced
Ca2 transients.
In summary, the work described here provides for some
insight on the mechanisms of EGFR signal transduction. In
agreement with previous reports (Gadella and Jovin, 1995;
Verveer et al., 2000; Moriki et al., 2001), our data have
shown that ligand-induced EGFR dimerization is not the
only mechanism of EGFR activation, and have found evi-
dence for a new signaling role for constitutive oligomeric
EGFRs. We have also provided data in support of the
occurrence of a structural change in the ectodomain of
EGFR, which may be necessary for signals to occur. The
observed rapid dissociation of EGFR after undergoing the
transient structure change suggests that EGFR dimers are
not stable for very long after signaling. It is conceivable that
the newly dissociated receptors could subsequently interact
with unliganded nonphosphorylated monomeric EGFRs to
form secondary oligomers, and in this way propagate sig-
nals along the plasma membrane, as previously observed by
other methods (Defize et al., 1989; Gamett et al., 1997;
Verveer et al., 2000).
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